The 3rd Annual RNAi – Based Therapeutics Summit Returns!
successfully develop targeted extrahepatic RNAi drugs
jenna.warren@hansonwade.com
Clinical, drug development, Life Science, pharma, RNAi
0 Comment
successfully develop targeted extrahepatic RNAi drugs
jenna.warren@hansonwade.com
Biotech, Kynerva Therapeutics, pharma, Roche, Treg
0 Comment
See the full potential of Treg therapies
jenna.warren@hansonwade.com
Clinical, drug development, Kinase, Kinase Inhibitor, Targeted Therapies
0 Comment
Advance Targeting of the Kinome to Overcome Resistance
jenna.warren@hansonwade.com
drug development, Mitochondria, Mitochondrial Dysfunction, neurodegenerative, Rare diseases
0 Comment
Therapies for mitochondrial dysfunction
jenna.warren@hansonwade.com
drug development, IFF, microbiome, Microbiome-based Therapeutics, Seventure
0 Comment
New generation of microbiome-targeted therapeutics
jenna.warren@hansonwade.com
drug discovery, immuno-oncology, infectious diseases, inflammasome, innate immunity
0 Comment
Targeting the Inflammasome
Events/ Events/ Partner Content
jenna.warren@hansonwade.com
immunogenic, infectious disease, SARS-CoV-2, T-cell, vaccine
0 Comment
Cell-Mediated Therapies for Infectious Disease Summit
Events/ Events/ Partner Content
jenna.warren@hansonwade.com
drug deiscovery, induced-proximity, multispecific medicines
0 Comment
Induced Proximity-Based Drug Discovery Summit
jenna.warren@hansonwade.com
allogeneic, car-tcr, Engineering, fda, TCR
0 Comment
6th CAR-TCR Summit – Aug 30 – Sep 2, 2021